Comparison of ringer with ringer lactate as a prime solution in coronary artery bypass graft

Phase 2

Recruiting

• Conditions: Coronary Artery Bypass Graft Surgery.; Atherosclerotic heart disease of native coronary artery; I25.1

• Registration Number: IRCT20141009019470N94
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Patients Candidate for Coronary Artery Bypass Graft Surgery
Age 20 to 75 years
Weight less than 50 kg and over 100 kg

Exclusion Criteria

Cardiopulmonary pump duration over 3 hours
Emergency surgery
Chronic renal failure
Anemia (Hb <10 g / dl)
Coagulopathy
Pulmonary Failure
Diabetes mellitus
Liver problem
Acid-disorder disturbance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood PH. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.;Serum bicarbonate level. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.

Secondary Outcome Measures

Name	Time	Method
Base excess. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.;PaCO2. Timepoint: 15 minutes after the start of cardiopulmonary bypass, in the warm-up phase at 34 ° C. Method of measurement: Arterial blood sample.